Cyclopharm Ltd
ASX:CYC
EV/GP
Enterprise Value to Gross Profit
Market Cap | EV/GP | ||||
---|---|---|---|---|---|
AU |
C
|
Cyclopharm Ltd
ASX:CYC
|
160m AUD | 8.7 | |
US |
Abbott Laboratories
NYSE:ABT
|
182.3B USD | 8.4 | ||
US |
Intuitive Surgical Inc
NASDAQ:ISRG
|
135.1B USD | 26.8 | ||
US |
Stryker Corp
NYSE:SYK
|
123.6B USD | 9.8 | ||
IE |
Medtronic PLC
NYSE:MDT
|
111.1B USD | 6 | ||
US |
Boston Scientific Corp
NYSE:BSX
|
107B USD | 11.2 | ||
US |
Becton Dickinson and Co
NYSE:BDX
|
68.5B USD | 10.1 | ||
DE |
Siemens Healthineers AG
XETRA:SHL
|
58.9B EUR | 8.9 | ||
CN |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
371.2B CNY | 15.1 | ||
US |
Edwards Lifesciences Corp
NYSE:EW
|
51B USD | 10.6 | ||
US |
Dexcom Inc
NASDAQ:DXCM
|
49.5B USD | 20.4 |
EV/GP Forward Multiples
Forward EV/GP multiple is a version of the EV/GP ratio that uses forecasted gross profit for the EV/GP calculation. 1-Year, 2-Years, and 3-Years forwards use gross profit forecasts for 1, 2, and 3 years ahead, respectively.